Report Overview
Oral Transmucosal Drugs
This report provides a deep insight into the global Oral Transmucosal Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oral Transmucosal Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oral Transmucosal Drugs market in any manner.
Global Oral Transmucosal Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Market Segmentation (by Type)
Tablets
Films
Liquid Spray
Gels
Others
Market Segmentation (by Application)
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Oral Transmucosal Drugs Market
? Overview of the regional outlook of the Oral Transmucosal Drugs Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Transmucosal Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oral Transmucosal Drugs
1.2 Key Market Segments
1.2.1 Oral Transmucosal Drugs Segment by Type
1.2.2 Oral Transmucosal Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oral Transmucosal Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Oral Transmucosal Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oral Transmucosal Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oral Transmucosal Drugs Market Competitive Landscape
3.1 Global Oral Transmucosal Drugs Sales by Manufacturers (2019-2024)
3.2 Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oral Transmucosal Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oral Transmucosal Drugs Sales Sites, Area Served, Product Type
3.6 Oral Transmucosal Drugs Market Competitive Situation and Trends
3.6.1 Oral Transmucosal Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Transmucosal Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oral Transmucosal Drugs Industry Chain Analysis
4.1 Oral Transmucosal Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oral Transmucosal Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oral Transmucosal Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Transmucosal Drugs Sales Market Share by Type (2019-2024)
6.3 Global Oral Transmucosal Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Oral Transmucosal Drugs Price by Type (2019-2024)
7 Oral Transmucosal Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Transmucosal Drugs Market Sales by Application (2019-2024)
7.3 Global Oral Transmucosal Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Oral Transmucosal Drugs Sales Growth Rate by Application (2019-2024)
8 Oral Transmucosal Drugs Market Segmentation by Region
8.1 Global Oral Transmucosal Drugs Sales by Region
8.1.1 Global Oral Transmucosal Drugs Sales by Region
8.1.2 Global Oral Transmucosal Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Oral Transmucosal Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Transmucosal Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Transmucosal Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oral Transmucosal Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Transmucosal Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 LTS Lohmann Therapie-Systeme AG
9.1.1 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Basic Information
9.1.2 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Overview
9.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Market Performance
9.1.4 LTS Lohmann Therapie-Systeme AG Business Overview
9.1.5 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs SWOT Analysis
9.1.6 LTS Lohmann Therapie-Systeme AG Recent Developments
9.2 Soligenix
9.2.1 Soligenix Oral Transmucosal Drugs Basic Information
9.2.2 Soligenix Oral Transmucosal Drugs Product Overview
9.2.3 Soligenix Oral Transmucosal Drugs Product Market Performance
9.2.4 Soligenix Business Overview
9.2.5 Soligenix Oral Transmucosal Drugs SWOT Analysis
9.2.6 Soligenix Recent Developments
9.3 ZIM Laboratories Limited
9.3.1 ZIM Laboratories Limited Oral Transmucosal Drugs Basic Information
9.3.2 ZIM Laboratories Limited Oral Transmucosal Drugs Product Overview
9.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Product Market Performance
9.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs SWOT Analysis
9.3.5 ZIM Laboratories Limited Business Overview
9.3.6 ZIM Laboratories Limited Recent Developments
9.4 Access Pharmaceutical Inc.
9.4.1 Access Pharmaceutical Inc. Oral Transmucosal Drugs Basic Information
9.4.2 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Overview
9.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Market Performance
9.4.4 Access Pharmaceutical Inc. Business Overview
9.4.5 Access Pharmaceutical Inc. Recent Developments
9.5 C.L Pharm
9.5.1 C.L Pharm Oral Transmucosal Drugs Basic Information
9.5.2 C.L Pharm Oral Transmucosal Drugs Product Overview
9.5.3 C.L Pharm Oral Transmucosal Drugs Product Market Performance
9.5.4 C.L Pharm Business Overview
9.5.5 C.L Pharm Recent Developments
9.6 Cure Pharmaceutical
9.6.1 Cure Pharmaceutical Oral Transmucosal Drugs Basic Information
9.6.2 Cure Pharmaceutical Oral Transmucosal Drugs Product Overview
9.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Product Market Performance
9.6.4 Cure Pharmaceutical Business Overview
9.6.5 Cure Pharmaceutical Recent Developments
9.7 Aquestive Therapeutics, Inc.
9.7.1 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Basic Information
9.7.2 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Overview
9.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Market Performance
9.7.4 Aquestive Therapeutics, Inc. Business Overview
9.7.5 Aquestive Therapeutics, Inc. Recent Developments
9.8 NAL Pharma
9.8.1 NAL Pharma Oral Transmucosal Drugs Basic Information
9.8.2 NAL Pharma Oral Transmucosal Drugs Product Overview
9.8.3 NAL Pharma Oral Transmucosal Drugs Product Market Performance
9.8.4 NAL Pharma Business Overview
9.8.5 NAL Pharma Recent Developments
9.9 IntelGenx Corp.
9.9.1 IntelGenx Corp. Oral Transmucosal Drugs Basic Information
9.9.2 IntelGenx Corp. Oral Transmucosal Drugs Product Overview
9.9.3 IntelGenx Corp. Oral Transmucosal Drugs Product Market Performance
9.9.4 IntelGenx Corp. Business Overview
9.9.5 IntelGenx Corp. Recent Developments
9.10 Eisai Co., Ltd.
9.10.1 Eisai Co., Ltd. Oral Transmucosal Drugs Basic Information
9.10.2 Eisai Co., Ltd. Oral Transmucosal Drugs Product Overview
9.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Product Market Performance
9.10.4 Eisai Co., Ltd. Business Overview
9.10.5 Eisai Co., Ltd. Recent Developments
9.11 Otsuka Pharmaceutical Co., Ltd.
9.11.1 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Basic Information
9.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Overview
9.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Market Performance
9.11.4 Otsuka Pharmaceutical Co., Ltd. Business Overview
9.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
9.12 Teva Pharmaceutical Industries Ltd.
9.12.1 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Basic Information
9.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Overview
9.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Market Performance
9.12.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.13 GlaxoSmithKline plc
9.13.1 GlaxoSmithKline plc Oral Transmucosal Drugs Basic Information
9.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Product Overview
9.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Product Market Performance
9.13.4 GlaxoSmithKline plc Business Overview
9.13.5 GlaxoSmithKline plc Recent Developments
9.14 Viatris
9.14.1 Viatris Oral Transmucosal Drugs Basic Information
9.14.2 Viatris Oral Transmucosal Drugs Product Overview
9.14.3 Viatris Oral Transmucosal Drugs Product Market Performance
9.14.4 Viatris Business Overview
9.14.5 Viatris Recent Developments
9.15 Bristol-Myers Squibb Company
9.15.1 Bristol-Myers Squibb Company Oral Transmucosal Drugs Basic Information
9.15.2 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Overview
9.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Market Performance
9.15.4 Bristol-Myers Squibb Company Business Overview
9.15.5 Bristol-Myers Squibb Company Recent Developments
10 Oral Transmucosal Drugs Market Forecast by Region
10.1 Global Oral Transmucosal Drugs Market Size Forecast
10.2 Global Oral Transmucosal Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Transmucosal Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Oral Transmucosal Drugs Market Size Forecast by Region
10.2.4 South America Oral Transmucosal Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oral Transmucosal Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oral Transmucosal Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oral Transmucosal Drugs by Type (2025-2030)
11.1.2 Global Oral Transmucosal Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oral Transmucosal Drugs by Type (2025-2030)
11.2 Global Oral Transmucosal Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Oral Transmucosal Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Oral Transmucosal Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oral Transmucosal Drugs Market Size Comparison by Region (M USD)
Table 5. Global Oral Transmucosal Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oral Transmucosal Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oral Transmucosal Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Transmucosal Drugs as of 2022)
Table 10. Global Market Oral Transmucosal Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oral Transmucosal Drugs Sales Sites and Area Served
Table 12. Manufacturers Oral Transmucosal Drugs Product Type
Table 13. Global Oral Transmucosal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oral Transmucosal Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oral Transmucosal Drugs Market Challenges
Table 22. Global Oral Transmucosal Drugs Sales by Type (Kilotons)
Table 23. Global Oral Transmucosal Drugs Market Size by Type (M USD)
Table 24. Global Oral Transmucosal Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oral Transmucosal Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Oral Transmucosal Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Oral Transmucosal Drugs Market Size Share by Type (2019-2024)
Table 28. Global Oral Transmucosal Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oral Transmucosal Drugs Sales (Kilotons) by Application
Table 30. Global Oral Transmucosal Drugs Market Size by Application
Table 31. Global Oral Transmucosal Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oral Transmucosal Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Oral Transmucosal Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Oral Transmucosal Drugs Market Share by Application (2019-2024)
Table 35. Global Oral Transmucosal Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Oral Transmucosal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oral Transmucosal Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Oral Transmucosal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oral Transmucosal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oral Transmucosal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oral Transmucosal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oral Transmucosal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Basic Information
Table 44. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Overview
Table 45. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. LTS Lohmann Therapie-Systeme AG Business Overview
Table 47. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs SWOT Analysis
Table 48. LTS Lohmann Therapie-Systeme AG Recent Developments
Table 49. Soligenix Oral Transmucosal Drugs Basic Information
Table 50. Soligenix Oral Transmucosal Drugs Product Overview
Table 51. Soligenix Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Soligenix Business Overview
Table 53. Soligenix Oral Transmucosal Drugs SWOT Analysis
Table 54. Soligenix Recent Developments
Table 55. ZIM Laboratories Limited Oral Transmucosal Drugs Basic Information
Table 56. ZIM Laboratories Limited Oral Transmucosal Drugs Product Overview
Table 57. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. ZIM Laboratories Limited Oral Transmucosal Drugs SWOT Analysis
Table 59. ZIM Laboratories Limited Business Overview
Table 60. ZIM Laboratories Limited Recent Developments
Table 61. Access Pharmaceutical Inc. Oral Transmucosal Drugs Basic Information
Table 62. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Overview
Table 63. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Access Pharmaceutical Inc. Business Overview
Table 65. Access Pharmaceutical Inc. Recent Developments
Table 66. C.L Pharm Oral Transmucosal Drugs Basic Information
Table 67. C.L Pharm Oral Transmucosal Drugs Product Overview
Table 68. C.L Pharm Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. C.L Pharm Business Overview
Table 70. C.L Pharm Recent Developments
Table 71. Cure Pharmaceutical Oral Transmucosal Drugs Basic Information
Table 72. Cure Pharmaceutical Oral Transmucosal Drugs Product Overview
Table 73. Cure Pharmaceutical Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Cure Pharmaceutical Business Overview
Table 75. Cure Pharmaceutical Recent Developments
Table 76. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Basic Information
Table 77. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Overview
Table 78. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Aquestive Therapeutics, Inc. Business Overview
Table 80. Aquestive Therapeutics, Inc. Recent Developments
Table 81. NAL Pharma Oral Transmucosal Drugs Basic Information
Table 82. NAL Pharma Oral Transmucosal Drugs Product Overview
Table 83. NAL Pharma Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. NAL Pharma Business Overview
Table 85. NAL Pharma Recent Developments
Table 86. IntelGenx Corp. Oral Transmucosal Drugs Basic Information
Table 87. IntelGenx Corp. Oral Transmucosal Drugs Product Overview
Table 88. IntelGenx Corp. Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. IntelGenx Corp. Business Overview
Table 90. IntelGenx Corp. Recent Developments
Table 91. Eisai Co., Ltd. Oral Transmucosal Drugs Basic Information
Table 92. Eisai Co., Ltd. Oral Transmucosal Drugs Product Overview
Table 93. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eisai Co., Ltd. Business Overview
Table 95. Eisai Co., Ltd. Recent Developments
Table 96. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Basic Information
Table 97. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Overview
Table 98. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Otsuka Pharmaceutical Co., Ltd. Business Overview
Table 100. Otsuka Pharmaceutical Co., Ltd. Recent Developments
Table 101. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Basic Information
Table 102. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Overview
Table 103. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Teva Pharmaceutical Industries Ltd. Business Overview
Table 105. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 106. GlaxoSmithKline plc Oral Transmucosal Drugs Basic Information
Table 107. GlaxoSmithKline plc Oral Transmucosal Drugs Product Overview
Table 108. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. GlaxoSmithKline plc Business Overview
Table 110. GlaxoSmithKline plc Recent Developments
Table 111. Viatris Oral Transmucosal Drugs Basic Information
Table 112. Viatris Oral Transmucosal Drugs Product Overview
Table 113. Viatris Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Viatris Business Overview
Table 115. Viatris Recent Developments
Table 116. Bristol-Myers Squibb Company Oral Transmucosal Drugs Basic Information
Table 117. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Overview
Table 118. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Bristol-Myers Squibb Company Business Overview
Table 120. Bristol-Myers Squibb Company Recent Developments
Table 121. Global Oral Transmucosal Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Oral Transmucosal Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Oral Transmucosal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Oral Transmucosal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Oral Transmucosal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Oral Transmucosal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Oral Transmucosal Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Oral Transmucosal Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Oral Transmucosal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Oral Transmucosal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Oral Transmucosal Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Oral Transmucosal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Oral Transmucosal Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Oral Transmucosal Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Oral Transmucosal Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Oral Transmucosal Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Oral Transmucosal Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Oral Transmucosal Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oral Transmucosal Drugs Market Size (M USD), 2019-2030
Figure 5. Global Oral Transmucosal Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Oral Transmucosal Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oral Transmucosal Drugs Market Size by Country (M USD)
Figure 11. Oral Transmucosal Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Oral Transmucosal Drugs Revenue Share by Manufacturers in 2023
Figure 13. Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oral Transmucosal Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oral Transmucosal Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oral Transmucosal Drugs Market Share by Type
Figure 18. Sales Market Share of Oral Transmucosal Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Oral Transmucosal Drugs by Type in 2023
Figure 20. Market Size Share of Oral Transmucosal Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Oral Transmucosal Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oral Transmucosal Drugs Market Share by Application
Figure 24. Global Oral Transmucosal Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Oral Transmucosal Drugs Sales Market Share by Application in 2023
Figure 26. Global Oral Transmucosal Drugs Market Share by Application (2019-2024)
Figure 27. Global Oral Transmucosal Drugs Market Share by Application in 2023
Figure 28. Global Oral Transmucosal Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oral Transmucosal Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oral Transmucosal Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oral Transmucosal Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oral Transmucosal Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oral Transmucosal Drugs Sales Market Share by Country in 2023
Figure 37. Germany Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oral Transmucosal Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oral Transmucosal Drugs Sales Market Share by Region in 2023
Figure 44. China Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oral Transmucosal Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Oral Transmucosal Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oral Transmucosal Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oral Transmucosal Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oral Transmucosal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oral Transmucosal Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oral Transmucosal Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oral Transmucosal Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oral Transmucosal Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Oral Transmucosal Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Oral Transmucosal Drugs Market Share Forecast by Application (2025-2030)
